Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time

BACKGROUND: The chromogenic anti‐Xa assay, the gold standard for monitoring the anti‐Xa effect of rivaroxaban, is not available as a cage‐side diagnostic test for use in a clinical setting. HYPOTHESIS/OBJECTIVES: To evaluate clinical modalities for measuring the anticoagulant effects of rivaroxaban...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Junwoo, Kim, Hyunwoo, Kim, Woosun, Kim, Suhee, Park, Jinho, Jung, Dong‐In, Yu, Dohyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524124/
https://www.ncbi.nlm.nih.gov/pubmed/30859645
http://dx.doi.org/10.1111/jvim.15478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524124/
https://www.ncbi.nlm.nih.gov/pubmed/30859645
http://dx.doi.org/10.1111/jvim.15478

Ejemplares similares